Would modulation of intracellular Ca2+ be antiarrhythmic?

Penelope A Boyden1, Henk ter Keurs

  • 1Department of Pharmacology, Center for Molecular Therapeutics, Columbia University, NY 10032, USA. pab4@columbia.edu

Insights

Reversal of excitation-contraction coupling (RECC) can cause abnormal heart rhythms. This review examines how calcium dysregulation in cardiac cells initiates RECC and leads to arrhythmias.

Area of Science:

  • Cardiology
  • Molecular Biology
  • Electrophysiology

Background:

  • Abnormal electrical activity in the heart can arise from the reversal of excitation-contraction coupling (RECC).
  • Understanding the triggers and mechanisms of RECC is crucial for managing cardiac arrhythmias.

Purpose of the Study:

  • To review conditions leading to RECC in various cardiac cell types.
  • To explore the role of calcium (Ca2+) dysregulation in initiating RECC and subsequent arrhythmias.
  • To examine Ca2+-dependent ion channel function and potential therapeutic agents.

Main Methods:

  • Literature review of studies on RECC and cardiac electrical activity.
  • Analysis of Ca2+ handling abnormalities in SA, atrial, Purkinje, and ventricular cells.
  • Examination of molecular interactions between Ca2+ and ion channels involved in arrhythmias.

Main Results:

  • Abnormal spontaneous Ca2+ release, aberrant Ca2+ influx, or Ca2+ surges can initiate RECC.
  • Increased intracellular Ca2+ often triggers spontaneous Ca2+ waves, leading to membrane depolarization.
  • Ca2+-dependent changes in ion channel function are key to RECC-induced electrical disturbances.

Conclusions:

  • Dysfunctional Ca2+ handling is a primary driver of RECC and non-driven cardiac electrical activity.
  • Understanding Ca2+-dependent processes is vital for developing treatments for genetic arrhythmias.
  • Targeting Ca2+-dependent mechanisms may offer therapeutic strategies for arrhythmias.

Related Concept Videos

Calmodulin-dependent Signaling01:16

Calmodulin-dependent Signaling

Calmodulin (CaM) is a calcium-binding protein in eukaryotes that controls various calcium-regulated cellular processes. It has four calcium-binding sites that bind calcium to form the calcium-calmodulin ( Ca2+-CaM) complex. GPCR stimulation increases the calcium levels in the cells that bind to CaM and induces a conformational change.
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers01:22

Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers

Class I antiarrhythmic drugs are used to treat various types of arrhythmias or irregular heart rhythms. These drugs block the sodium (Na+) channels in the cardiac cells, thereby affecting the movement of electrical impulses across the heart. Class I antiarrhythmic drugs are divided into three subgroups: Class IA, Class IB, and Class IC, each with distinct mechanisms of action and effects on the heart.
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
Feedback Regulation of Calcium Concentration01:27

Feedback Regulation of Calcium Concentration

Calcium is an essential signaling molecule required for various cellular functions. Calcium pumps and ion channels on cell and organellar membranes, such as those on the endoplasmic reticulum (ER), regulate calcium concentrations inside the cell. They remain closed, keeping the cytosolic calcium levels low at a resting state.
Various transmembrane receptors, such as G protein-coupled receptors (GPCRs), elicit a response to extracellular signals by increasing cytosolic calcium. Activated GPCRs...
Heart Failure Drugs: Inotropic Agents01:26

Heart Failure Drugs: Inotropic Agents

Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
Mechanism of Cardiac Arrhythmias01:28

Mechanism of Cardiac Arrhythmias

Arrhythmias are irregular heart rhythms occurring when the heart's electrical impulses become abnormal. These disturbances can lead to various symptoms, depending on their severity and the underlying cause. Some common factors contributing to arrhythmias include hypoxia, ischemia, electrolyte imbalances, excessive catecholamine exposure, drug toxicity, and muscle overstretching. Arrhythmias can be classified into two main types based on the rate and site of origin of abnormal heart rhythms.
G-Protein Gated Ion Channels01:21

G-Protein Gated Ion Channels

GPCRs are primarily responsible for our sense of smell, taste, and vision.  The binding of a sensory stimulus activates GPCR to stimulate effector proteins, many of which are ion channels in the sensory organs. GPCRs modulate the opening and closing of the target ion channels either directly by binding them, or by releasing second messengers that activate these channels. As ions move across the membrane, the membrane potential is altered, which induces an appropriate response.
Sensory organs,...